Higher cholesterol level is a risk factor of coronary artery disease, the major cause of sudden cardiac death (SCD). However, smaller studies observed worse outcomes in SCD patients having lower total and LDL-cholesterol levels. Therefore, the prognostic role of cholesterol itself in patients with SCD remains to be clarified. We aimed to assess the relationship of on-admission cholesterol level to the neurological outcome in a secondary analysis of the randomized Prague OHCA trial population (extracorporeal cardiopulmonary resuscitation (ECPR) vs. standard approach in refractory cardiac arrest). Of 256 included patients with refractory cardiac arrest, 123 were analyzed. The effects of total, HDL and non-HDL cholesterol levels drawn at admission on the best cerebral performance category (CPC) within 180 days were examined. Results are presented as median (interquartile range) and differences compared by the Wilcoxon test. Patients with CPC 1-2 had higher initial levels of total cholesterol [3.70 (3.23-4.27) mmol/L vs. 2.98 (2.35-4.02) mmol/L, p = 0.005], non-HDL cholesterol [2.68 (2.08-3.24) vs. 1.93 (1.62-2.97) mmol/L, p = 0.007 and HDL-cholesterol [0.93 (0.67-1.07) mmol/L vs. 0.74 (0.49-0.96) mmol/L, p = 0.014] compared to patients with CPC 3-5. Chronic use of statins did not influence the outcome. Only the low levels of total and non-HDL cholesterol remained consistent predictors of poor neurological outcomes in all patients and in both separate arms. Lower total and non-HDL cholesterol levels on admission are associated with worse neurological outcomes in patients with refractory cardiac arrest treated by both ECPR and standard approach.

Complex Cardiovascular Center 1st Faculty of Medicine General University Hospital Charles University U nemocnice 2 128 08 Prague 2 Czech Republic

Zobrazit více v PubMed

Belohlavek, J. et al. Effect of Intra-arrest transport, extracorporeal cardiopulmonary resuscitation, and immediate invasive assessment and treatment on functional neurologic outcome in refractory out-of-hospital cardiac arrest: A randomized clinical trial. PubMed PMC

Rob, D. et al. Extracorporeal versus conventional cardiopulmonary resuscitation for refractory out-of-hospital cardiac arrest: A secondary analysis of the Prague OHCA trial. PubMed PMC

Rob, D. et al. Effect of intra-arrest transport, extracorporeal cardiopulmonary resuscitation and immediate invasive assessment in refractory out-of-hospital cardiac arrest: a long-term follow-up of the Prague OHCA trial. PubMed PMC

Farb, A. et al. Sudden coronary death. Frequency of active coronary lesions, inactive coronary lesions, and myocardial infarction. PubMed

Hayashi, M., Shimizu, W. & Albert, C. M. The spectrum of epidemiology underlying sudden cardiac death. PubMed PMC

Lott, C. et al. European resuscitation council guidelines 2021: Cardiac arrest in special circumstances. PubMed

Chae, M. K., Lee, S. E., Min, Y. G. & Park, E. J. Initial serum cholesterol level as a potential marker for post cardiac arrest patient outcomes. PubMed

Lee, H. Y. et al. The association between lipid profiles and the neurologic outcome in patients with out-of-hospital cardiac arrest. PubMed

Yang, J. K. et al. Low serum cholesterol level as a risk factor for out-of-hospital cardiac arrest: A case control study. PubMed PMC

Lee, J. et al. Association between initial serum cholesterol levels and outcomes of patients hospitalized after Out-of-Hospital cardiac arrest: A retrospective multicenter registry study. PubMed PMC

Belohlavek, J. et al. Hyperinvasive approach to out-of hospital cardiac arrest using mechanical chest compression device, prehospital intraarrest cooling, extracorporeal life support and early invasive assessment compared to standard of care. A randomized parallel groups comparative study proposal. Prague OHCA study. PubMed PMC

Hosadurg, N. et al. Lipid profiles in out-of-hospital sudden unexpected death. PubMed PMC

Ahn, C. et al. Serum total cholesterol level as a potential predictive biomarker for neurological outcomes in cardiac arrest survivors who underwent target temperature management. PubMed PMC

Bleske, B. E., Song, J., Chow, M. S., Kluger, J. & White, C. M. Hematologic and chemical changes observed during and after cardiac arrest in a canine model–a pilot study. PubMed

Vatassery, G. T., Smith, W. E., Quach, H. T. & Lai, J. C. In vitro oxidation of vitamin E, vitamin C, thiols and cholesterol in rat brain mitochondria incubated with free radicals. PubMed

Adrie, C. et al. Postresuscitation disease after cardiac arrest: a sepsis-like syndrome? PubMed

Cirstea, M. et al. Decreased high density lipoprotein cholesterol level is an early prognostic marker for organ dysfunction and death in patients with suspected sepsis. PubMed

Abdul Malick, A. et al. The utility of serial lipid measurements as a potential predictor of Sepsis outcome: A prospective observational study in a tertiary care hospital. PubMed PMC

Bakalar, B., Hyspler, R., Pachl, J. & Zadak, Z. Changes in cholesterol and its precursors during the 315 first days after major trauma. PubMed

Downs, J. R. et al. Primary prevention of acute coronary events with Lovastatin in men and women with average cholesterol levels: Results of afcaps/texcaps. Air force/texas coronary atherosclerosis prevention study. PubMed

Mach, F. et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. PubMed

Kim, Y. G. et al. Association between low-density lipoprotein cholesterol and sudden cardiac arrest in people with diabetes mellitus. PubMed PMC